On ECHEMI
Home > Drugs > Aspartylglucosaminuria
Aspartylglucosaminuria
Aspartylglucosaminuria is an autosomal recessive genetic disease caused by a deficiency of aspartylglucosaminidase in the body, characterized by mental retardation, coarse facial features, multiple bone dysplasias, vacuoles in lymphocytes in the peripheral blood, and the absence of mucopolysacchariduria.
  • Site of disease:

    Bone blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Language disorder short neck recurrent upper respiratory tract infection obvious cheek indentation recurrent upper respiratory tract infection
Related Drugs
Calcium Gluconate Oral Solution
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Hubei Newland Pharmaceutical Co., Ltd.

Calcium Gluconate Oral Solution
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

Zhejiang Tianyitang Pharmaceutical Co., Ltd.

Calcium Gluconate Oral Solution
Indication: Used to prevent and treat calcium deficiency diseases such as osteoporosis, tetany, bone dysplasia, rickets, and as calcium supplement for children, pregnant and lactating women, menopausal women, and the elderly.
Manufacturer:

China Resources Sanjiu (Huangshi) Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.